Trial Site Detail

 

Drug:
Crenolanib (CP-868,596)
Trial:
Phase II Study of Crenolanib (CP-868,596), for the Treatment of Patients With Advanced Gastrointestinal Stromal Tumors With the D842-related Mutations and Deletions in the PDGFRA Gene
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Fox Chase Cancer Center

333 Cottman Ave     
Philadelphia , PA 19111
USA

 

Principal Investigator:
Margeret von Mehren, M.D.
Contact:
Kathleen Lear, RN, OCN, CCRP 215-214-1511 Kathleen.Lear@fccc.edu
Activation Status of this Site:
Closed
Notes about this Site:
Fox Chase Cancer Center Website:
https://www.protonet.fccc.edu/fccc/pims/

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.